Description

Salofalk (mesalazine) rectal suppositories 250 mg. №10

Ingredients:

Each rectal suppository contains 250 mg of mesalazine.

Dosage:

The usual dosage is one suppository inserted into the rectum once daily, preferably at bedtime.

Indications:

Salofalk suppositories are indicated for the treatment of mild to moderate ulcerative colitis and proctitis.

Contraindications:

Do not use Salofalk suppositories if you are allergic to mesalazine or any other ingredients in the product.

Directions:

Before using the suppository, empty your bowels. Remove the foil wrapping and insert the suppository into the rectum as directed.

Scientific Evidence:

Studies have shown that mesalazine, the active ingredient in Salofalk suppositories, is effective in reducing inflammation in the colon and rectum. Research published in the Journal of Crohn’s and Colitis demonstrated the efficacy of mesalazine in inducing and maintaining remission in patients with ulcerative colitis.

Additional Information:

It is important to follow the prescribed dosage and treatment regimen as directed by your healthcare provider to achieve the best results with Salofalk suppositories. If you experience any unusual symptoms or side effects, consult your doctor immediately.

Salofalk suppositories offer a targeted approach to treating ulcerative colitis by delivering the medication directly to the affected area. This can help minimize systemic side effects often associated with oral medications.